Virpax Pharmaceuticals Inc (VRPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 5,904 | 5,124 | 4,122 | 3,250 | 2,306 |
| Operating Income | -5,904 | -5,124 | -4,122 | -3,250 | -2,306 |
| Interest Expense | 0 | 0 | -1 | 29 | 34 |
| Other Income | 19 | -13 | 3 | 63 | -4 |
| Pre-tax Income | -5,885 | -5,137 | -4,118 | -3,216 | -2,343 |
| Net Income Continuous | -5,885 | -5,137 | -4,118 | -3,216 | -2,343 |
| Net Income | $-5,885 | $-5,137 | $-4,118 | $-3,216 | $-2,343 |
| EPS Basic Total Ops | -125.00 | -110.00 | -52.50 | -132.50 | -117.50 |
| EPS Basic Continuous Ops | -125.60 | -109.68 | -48.75 | -133.73 | -118.14 |
| EPS Diluted Total Ops | -125.00 | -110.00 | -52.50 | -132.50 | -117.50 |
| EPS Diluted Continuous Ops | -125.60 | -109.68 | -48.75 | -133.73 | -118.14 |
| EBITDA(a) | $-5,904 | $-5,124 | $-4,122 | $-3,250 | $-2,306 |